Invention Grant
- Patent Title: Fully human anti-human NKG2D monoclonal antibodies
- Patent Title (中): 全人类抗人NKG2D单克隆抗体
-
Application No.: US13057092Application Date: 2009-07-31
-
Publication No.: US09273136B2Publication Date: 2016-03-01
- Inventor: Christoph Rader , Ka Yin Kwong
- Applicant: Christoph Rader , Ka Yin Kwong
- Applicant Address: US MD Bethesda
- Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee Address: US MD Bethesda
- Agency: Leydig, Voit & Mayer, Ltd.
- International Application: PCT/US2009/052387 WO 20090731
- International Announcement: WO2010/017103 WO 20100211
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/28 ; A61K39/00
Abstract:
The invention relates to isolated fully human monoclonal antibodies having specificity for human NKG2D and compositions thereof. The invention further relates to methods for using such antibodies in treating diseases or conditions such as cancer, autoimmune disease, or infectious disease.
Public/Granted literature
- US20110150870A1 FULLY HUMAN ANTI-HUMAN NKG2D MONOCLONAL ANTIBODIES Public/Granted day:2011-06-23
Information query
